Arlington Partners LLC Viatris Inc Transaction History
Arlington Partners LLC
- $249 Million
- Q2 2025
Shares
3 transactions
Others Institutions Holding VTRS
# of Institutions
1,119Shares Held
981MCall Options Held
7.88MPut Options Held
2.91M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$938 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$797 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$672 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$560 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...